Crescendo Biologics and Cancer Research UK sign Clinical Development Partnership to develop CB213, a novel bispecific Humabody® therapeutic

Crescendo Biologics and Cancer Research UK sign Clinical Development Partnership to develop CB213, a novel bispecific Humabody® therapeutic

View PDF

Cell Engager Summit


Cell Engager Summit
James Legg presenting & Brian McGuinness attending
Boston, US

18-08-2020 00:00
20-08-2020 23:59
England/London
Cell Engager SummitBoston, US

BIO


BIO
Theodora Harold, Stewart Kay & James Legg attending
Virtual meeting 

08-06-2020 00:00
12-06-2020 23:59
England/London
BIOVirtual meeting

Jefferies


Jefferies
Theodora Harold presenting
Virtual meeting 

02-06-2020 00:00
04-06-2020 23:59
England/London
JefferiesVirtual meeting

ASCO


ASCO
Kenji Hashimoto & Stewart Kay attending
Virtual meeting 

29-05-2020 00:00
31-05-2020 23:59
England/London
ASCOVirtual meeting

AACR


AACR
James Legg presenting poster
Virtual meeting 

27-04-2020 00:00
28-04-2020 23:59
England/London
AACRVirtual meeting

Increased Tumor Penetration of Single-Domain Antibody Drug Conjugates Improves In Vivo Efficacy in Prostate Cancer Models

Increased Tumor Penetration of Single-Domain Antibody Drug Conjugates Improves In Vivo Efficacy in Prostate Cancer Models

View Paper